Cite
A naturalistic, 24-week, open-label, add-on study of vortioxetine in bipolar depression
MLA
Siwek, Marcin, et al. A Naturalistic, 24-Week, Open-Label, Add-on Study of Vortioxetine in Bipolar Depression. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..30df61ed4200373e6fcc0e6d2011a0f4&authtype=sso&custid=ns315887.
APA
Siwek, M., Chrobak, A., Sołtys, Z., Dudek, D., Krupa, A., & Rybakowski, J. K. (2022). A naturalistic, 24-week, open-label, add-on study of vortioxetine in bipolar depression.
Chicago
Siwek, Marcin, Adrian Chrobak, Zbigniew Sołtys, Dominika Dudek, Anna Krupa, and Janusz Kazimierz Rybakowski. 2022. “A Naturalistic, 24-Week, Open-Label, Add-on Study of Vortioxetine in Bipolar Depression,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..30df61ed4200373e6fcc0e6d2011a0f4&authtype=sso&custid=ns315887.